Aquestive Therapeutics (AQST) vs Cronos Group (CRON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cronos Group (CRON) has outperformed Aquestive Therapeutics (AQST) over the past year, gaining 23.7% versus a loss of 22.6%. Over five years, AQST leads with a +19.4% price change compared with -40.9% for CRON. Cronos Group is the larger company by market cap ($1.19 billion vs $597.4 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AQST | CRON |
|---|---|---|
| Share price | $4.76 | $3.22 |
| Market cap | $597.44M | $1.19B |
| 1-day change | +3.03% | -0.62% |
| YTD return | -28.48% | +23.19% |
| 1-year return | -22.61% | +23.66% |
| 5-year return | +19.38% | -40.88% |
| P/E ratio (TTM) | — | 16.95 |
| EPS (TTM) | $-0.66 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.55 | $3.61 |
| 52-week low | $2.93 | $2.28 |
| Distance from 52-week high | -36.95% | -10.75% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +96.01% | -23.60% |
| Average volume | 2.66M | 1.13M |
| Shares outstanding | 125.51M | 368.41M |
| Employees | 147 | 610 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CRON has outperformed AQST by 46.3 percentage points over the past year.
About Aquestive Therapeutics
AQST stock →Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 147 employees
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Health Care · Medicinal Chemicals and Botanical Products · 610 employees
AQST vs CRON FAQ
Which is bigger, Aquestive Therapeutics or Cronos Group?
Cronos Group (CRON) is larger, with a market capitalization of $1.19B compared with $597.44M for Aquestive Therapeutics (AQST).
Which stock has performed better over the past year, AQST or CRON?
CRON returned +23.66% over the past 12 months, compared with -22.61% for AQST (price return, excluding dividends). Past performance does not predict future results.
Are Aquestive Therapeutics and Cronos Group in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Aquestive Therapeutics and Medicinal Chemicals and Botanical Products for Cronos Group.